FIELD: pharmacology.
SUBSTANCE: invention relates to a compound of formula
and to pharmaceutical compositions based on it and to the application in the treatment or prevention of diabetes, diabetic retinopathy, diabetic neuropathy, atherosclerosis, abdominal aortic aneurysm, chronic kidney diseases and tumours.
EFFECT: compound of the formula can be used as a drug.
17 cl, 1 tbl, 52 ex
Title | Year | Author | Number |
---|---|---|---|
NOVEL PYRROLIDINE DERIVATIVES | 2017 |
|
RU2736498C1 |
TETRACYCLIC COMPOUNDS | 2010 |
|
RU2585622C2 |
TETRACYCLIC COMPOUNDS | 2010 |
|
RU2725140C2 |
NEW AZETIDINE DERIVATIVES | 2013 |
|
RU2629114C2 |
PYRROLIDINE DERIVATIVES APPLICABLE AS CATEPSIN DERIVATIVES | 2011 |
|
RU2548684C2 |
1,4 THIAZEPINES/SULPHONES AS BACE1 AND/OR BACE2 INHIBITORS | 2012 |
|
RU2600931C2 |
PIPERAZINO[1,2-A]INDOLE-1-ONES AND [1,4] DIAZEPTINO[1,2-A]INDOLE-1-ONE | 2014 |
|
RU2628126C2 |
NEW DERIVATIVES OF HETEROCYCLIC COMPOUNDS, PHARMACEUTICAL COMPOSITION, METHOD FOR MODULATION OF AUTOIMMUNE DISEASES, METHOD FOR PREPARING THESE COMPOUNDS | 2000 |
|
RU2255937C2 |
SUBSTITUTED PYRROLIDIN-2-CARBOXAMIDE | 2011 |
|
RU2564022C2 |
N-[3-(5-AMINO-3,3A,7,7A-TETRAHYDRO-1H-2,4-DIOXA-6-AZA-INDEN-7-YL)-PHENYL]-AMIDES AS INHIBITORS OF BACE1 AND(OR) BACE2 | 2012 |
|
RU2597308C2 |
Authors
Dates
2017-07-19—Published
2013-01-08—Filed